Search
+
    SEARCHED FOR:

    GLUCON D

    Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 24%

    Last few days of movement of the Nifty and Sense will make a number of people forget about what happened in March this year. The fact is that when valuations are high and they are even if takes into account the Q4 numbers. The probability of volatility hitting the street is always high. So, it would be better to stay ready for volatility both for domestic and global reasons. At this point of time, one cannot rule out sudden profit booking which can bring more damage to stock prices in the mid-cap segment. In such times, if one is taking fresh exposure to equity, ensure that there is some level of quality as far as the business and fundamentals are concerned. These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies that there has been a significant improvement in their market outlook in the given time.

    Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 35%

    In the first trading session post the formation of the new government, it is bulls which can be seen on the street and bears after their one day adventure are sitting on side. If one looks at the composition of the Nifty and sensex, they can be impacted by movement in one or two sectors and that is probably the reason why it is important to de-link with what is happening in nifty and broader market indices. Given the way indices and broader markets have panned out, it is very likely that we are going to soon see the market hitting new highs. But will your portfolio value hit a new high is something which needs to be watched. These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.

    FMCG sector: Street might treat it as saviors in some phases & there is more to it than HUL, 13 stocks, with upside potential of up to 42 %

    On the day of the election result and the day after that, two days in succession, everyone was talking about FMCG stocks. Explanations about why they are safe heaven stocks, how the focus on rural income and consumption will benefit them. Third day, the broader market recovered and FMCG was probably the only loser. This is not the first time that it has happened. For ages, FMCG stocks have been considered defensive stocks. Whether FMCG stocks should be defensive is a different issue. What is relevant is that there is a probability that going forward, there will be phases, where a narrative about FMCG stocks being defensive will keep coming to the street. Given the fact that their valuations are expensive, there is hardly any growth in business, it would be worthwhile to understand that sector otherwise one might end up buying stocks and make the capital underperform. We look at 28 stocks from every segment, right from food and beverage to cosmetics.

    For risk takers: 5 midcap stocks from different sectors with potential upside of up to 24%

    After months of relentless rally, last week mid-cap stocks witnessed some correction. Will this correction last longer would become clear in the coming few weeks as the earning season gets kicked off, analysts are bullish on select midcap stocks which have seen their score improving. Stocks from sectors like financial services, logistic are on the list. ET screener powered by Refinitiv’s Stock Report Plus applies different algorithms & filters to all BSE and NSE stocks, and lists stocks which fulfill the various criteria as specified into the algorithms & filters to find those which might help navigate the stock market.

    Zydus Lifesciences Q1 Results: Profit more than doubles on US sales growth

    Its U.S formulations business saw a revenue growth of 57.4% to 24.54 billion rupees, while India formulations grew by 9.1% to 12.27 billion rupees. India and U.S. sales make up 38% and 48% of Zydus' total revenue, respectively.

    HC restrains Cipla from using 'Gluco-C' or 'Gluco-D' trademarks

    ​​Zydus Wellness Products, which manufactures and sells energy drink GLUCON-C and GLUCON-D, had alleged that Cipla Health's Gluco-C and Gluco-D were deceptively similar to its registered trademarks.

    The Economic Times
    BACK TO TOP